See what we’re reading this week at Global Biodefense on pandemic flu outbreak vaccination scenarios, start of ZMapp trial in Liberia, 100 years of chemical weapons and more…
100 years of chemical weapons (C&EN)
ZMapp Ebola trial starts in Liberia: Is it too late? (Forbes)
WHO ‘taken aback’ by measles outbreaks (BBC News)
Practicing medicine in an era of antibiotic resistance (Pump Handle)
CHEMPACK Program – The stockpile that may protect you from a chemical attack (CDC)
Pakistani officials issue arrest warrants over refusals of polio vaccine (NY Times)
Vaccine hesitancy: Investigating vaccination decision-making (MNT)
ECBC Hosts Visiting Scientist from Netherland’s TNO (ECBC)
Researchers identify antibodies to fight Marburg virus (MNT)
NCT CBRNe Europe 2015 evaluates Ebola Response, the Ukraine crisis (IB Consultancy)
Public preferences under different pandemic flu outbreak scenarios (BMC Public Health)
The bacteria are winning: How to develop new antibiotics (NY Times)
Experts air concerns about federal gain-of-function review (CIDRAP)
O’Neill eyes up to $2 billion for fund to fight superbugs (Reuters)
Funding research for better water purification (Armed with Science)
Mass gatherings and measles (Bifurcated Needle)
Liberia: Burning Ebola waste safely (WHO)
Climate changes and the European outbreaks of bubonic plague (The Scientist)
The disease burden of influenza (CDC)
U.S. steps up commitment to fight malaria (NPR)
JIKI trial: Favipiravir shows some benefit in Ebola treatment (Healio)
Report slams U.S. Ebola response and readiness (NBC News)
Do you still have a Chief Pandemic Officer? (Avian Flu Diary)
NIH moving ahead with review of risky virology studies (Science)
Actavis’ superbug antibiotic gets U.S. approval (Reuters)
